Pharmaceutical Technology

SEPTEMBER 5, 2022

The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision. Quality in terms of number of defective items, packaging and labelling, quality management system certification, research, development, and innovation.

Packaging 130

Packaging Packaging Compliance Manufacturing 130

Pharmaceutical Technology

SEPTEMBER 7, 2022

The download contains detailed information on the providers and their services and solutions, alongside contact details to aid your purchasing decision. Patient adherence. Pharmaceutical companies are increasingly integrating data-driven and software-centric medical adherence products to improve patient compliance.

Pharmacy 130

Pharmacy Containment Manufacturing Compliance 130

Pharmaceutical Technology

SEPTEMBER 20, 2022

The information contained within the download document is intended for pharmaceutical manufacturers, wholesalers, retailers and distributors, pharmaceutical executives, medical representatives, business development managers, retail salesmen, sales managers, pharmacy executives, and any other individual involved in pharmaceutical marketing.

Marketing 130

Marketing Drug Delivery Systems Production Containment 130

Pharmaceutical Technology

SEPTEMBER 14, 2022

Victoza, Copaxone, Lupron, Zoladex, Sandostatin, and Somatuline are some of the popularly marketed peptide API therapeutic drugs while more than 600 peptide-based pharmacological leads are being investigated worldwide, across various phases of development. Technologies in the delivery of peptides and proteins.

Protein 130

Protein Marketing Manufacturing Reagent 130

Pharmaceutical Technology

SEPTEMBER 15, 2022

The information contained within the download document is intended for manufacturers, suppliers, distributors, pharmaceutical executives, medical representatives, distributors, pharmacists, business development managers, retail salesmen, sales managers, product marketing managers, and any other individual involved in drug injectables marketing.

Marketing 130

Marketing Containment Production Sales 130

Pharmaceutical Technology

MARCH 10, 2023

The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing decision. Role of freeze-drying systems in the pharmaceutical industry The pharmaceutical freeze-drying market is highly governed by stringent standards and laws.

Manufacturing 147

Manufacturing Production Containment Antibody 147

Pharmaceutical Technology

SEPTEMBER 7, 2022

The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision. . · Proprietary pharmaceutical, nutraceutical, and cosmeceutical products. Prescription collection lockers. Retail pharmacy trends.

Pharmacy 147

Pharmacy Containment Generic Drugs Production 147

Pharmaceutical Technology

SEPTEMBER 8, 2022

The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision. . · Clinical interventions, and psychosocial and emotional assessment. Trending technologies in speciality pharmacies.

Pharmacy 113

Pharmacy Containment Manufacturing Medicine 113

Pharmaceutical Technology

SEPTEMBER 8, 2022

Test method development. The information contained within the download document is intended for pharmacists, pharmaceutical executives, sales managers, manufacturers, business development managers, pharmaceutical sales representatives, and any other individual involved in the pharmaceutical compounding sector.

Marketing 130

Marketing Pharmacy Containment Sales 130

XTalks

MAY 13, 2022

A container closure system consists of all the packaging components that contain and protect a pharmaceutical product. Container Closure Systems. A container closure system protects the product from environmental conditions, safeguarding a product’s purity, strength, safety and efficacy. extractables and leachables).

Packaging 89

Packaging Packaging Containment Production 89

pharmaphorum

AUGUST 22, 2022

The two work perfectly in tandem and understanding their crucial relationship to each other is essential when developing a complete medical or commercial KOL strategy. . Business Development Account Manager. a: Sea Containers, 18 Upper Ground, London, SE1 9RQ. Robert Hollands. e: robert.hollands@vmlyr.com.

Nurses 52

Nurses Containment Business Development Development 52

The Pharma Data

OCTOBER 20, 2020

21, 2020 (GLOBE NEWSWIRE) — TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage, specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced the appointment of Thomas H. Earlier in his career, he ran business-development functions at Amgen and Baxter.

Licensing 40

Licensing Licensing Drug Delivery Business Development 40

XTalks

DECEMBER 8, 2021

Sweet also explored different development techniques with minimal processing. While it embodies all the properties of table sugar, Cambya contains no added sucrose or artificial additives. To ensure high solubility and blending capacity for easy integration into food and beverage products, B.T. Sweet, in the same press release.

Branding 105

Branding Manufacturing Marketing Production 105

XTalks

AUGUST 16, 2023

“We knew we had the opportunity to create something special when we saw the positive response to our previous seasonal collaborations for Dunkin’-inspired beers,” said Brian Gilbert, vice president of retail business development at Dunkin’, in a press release. ounce cans.

Branding 52

Branding Containment Marketing Business Development 52

The Pharma Data

JANUARY 20, 2021

STAFFORD, Texas–( BUSINESS WIRE )– Greenwich LifeSciences, Inc. Congressional agenda, the record setting pace of biotech IPOs, and the hottest clinical developments and industry catalysts. women will develop invasive breast cancer over her lifetime, with approximately 266,000 new breast cancer patients and 3.1

Containment 40

Containment Clinical Trials Clinical Trials Protein 40

pharmaphorum

FEBRUARY 3, 2022

Ensuring the sterility of the finished product continues to be one of the most critical aspects of drug development, however an array of factors are also sustaining new growth and transformation in this field. View the full agenda: [link]. Who Should Attend?

Contamination 52

Contamination Scientist Manufacturing Production 52

The Pharma Data

MAY 3, 2021

Lilly Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) related to expected dividend payments and potential share repurchases and reflects Lilly ‘s current beliefs and expectations.

Medicine 52

Medicine Containment Business Development Development 52

The Pharma Data

FEBRUARY 22, 2021

We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments. .

Production 52

Production Manufacturing Development Vaccine 52

The Pharma Data

AUGUST 6, 2020

We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

Business Development 52

Business Development Production Manufacturing Development 52

pharmaphorum

JANUARY 14, 2021

However, the company’s head of strategic business development Parsi Parsinejad said that the system is differentiated from competitors by its focus on putting patients in control of their data. Patient identified data is in a separate container from health data. The new Seqster 7.1

Trials 52

Trials Clinical Trials Clinical Trials Pharma Companies 52

The Pharma Data

JANUARY 12, 2021

Dr Graham is a medicines development expert and Infectious Diseases Epidemiologist with global Biotech and Pharma R&D experience in Phase I-IV therapeutics as well as in-vivo & in-vitro diagnostics, across many modalities. He has in depth Global Development Expertise (e.g. NEW YORK and LONDON, Jan. Dr. Graham earned an M.D.,

Life Science 52

Life Science Antibody In-Vivo In-Vitro 52

The Pharma Data

NOVEMBER 3, 2020

According to the FDA, the purpose of Fast Track designation is to get important new drugs to patients earlier by facilitating the development, and expediting the review, of drugs to treat serious conditions and fill an unmet medical need. LogicBio is also developing a Next Generation Capsid platform for use in gene editing and gene therapies.

Clinical Trials 52

Clinical Trials Clinical Trials Gene Editing Genome 52

The Pharma Data

SEPTEMBER 11, 2020

We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

Production 52

Production Manufacturing Vaccine Vaccination 52

The Pharma Data

NOVEMBER 9, 2020

IP-001 is the first of what is expected to be many novel agents and combinations that we bring into clinical development to help patients suffering from cancer.”. Contact: Dr. Theresa Visarius Vice President Business Development, Immunophotonics, Inc. Markus Jörger, M.D., The company is based in St.

Immune Response 40

Immune Response Clinical Trials Clinical Trials Trials 40

pharmaphorum

FEBRUARY 11, 2022

Sun says Komodo’s Healthcare Map has been built over the last seven and a half years and contains so much information that can help identify and treat patients with rare diseases. One is the platform, which is essentially what our internal solution developers capitalise on, and then we externalise that capability to third-party developers.”.

Life Science 105

Life Science Engineer Development Big Data 105

pharmaphorum

OCTOBER 12, 2022

Business Development Account Manager. a: Sea Containers, 18 Upper Ground, London, SE1 9RQ. Similar to a steering wheel in a car, quant is essential, however, you cannot get yourself and your passengers from A to B with just a steering wheel. Robert Hollands. KOL Insights at VMLY&R Health. e: robert.hollands@vmlyr.com.

Marketing 52

Marketing Containment Business Development Research 52

The Pharma Data

DECEMBER 17, 2020

George Yeh, President of TLC, commenced the conference and welcomed the company’s new Chief Business Officer, Mr. Tom Bliss. With experiences attained in licensing and business development functions from Amgen, Baxter and Johnson & Johnson, Mr. Bliss introduced himself in Mandarin Chinese. SOUTH SAN FRANCISCO, Calif.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Containment 40

pharmaphorum

JANUARY 28, 2021

This is significant because it opens several therapeutic areas for biosimilar development and, ultimately, increased competition. More than 30 million Americans have diabetes and another 88 million are at risk of developing it. Currently, more than seven million patients rely on insulin, and that number is growing each year.

Marketing 119

Marketing Insulin HR Production 119

The Pharma Data

NOVEMBER 10, 2020

Furthermore, data show that the class of drug substances being developed within AlzeCure’s platform, so-called gamma-secretory modulators, selectively affect the production of toxic Abeta-amyloid, without affecting the cleavage of other substrates that potentially play an important role in normal physiological function. in the brain.

Development 40

Development Drugs Protein Research 40

The Pharma Data

AUGUST 3, 2021

Revenue growth was 12 percent when excluding effects of 2020 COVID-related stocking patterns, revenue from COVID-19 antibodies and recent business development. “We delivered strong performance this quarter, with volume-driven growth across our core business and most major geographies. on a non-GAAP basis.

Antibody 52

Antibody Sales Development Production 52

The Pharma Data

JANUARY 4, 2021

Kiromic’s deep understanding of the tumor micro environment (TME) and the tumors’ escape and masking mechanisms led to development of a promising platform for chimeric antigen receptor therapy (CAR-T). PD-1 has always been a challenge for CAR-T development. “We believe Prof. About PD-1 Check-point inhibition.

In-Vivo 40

In-Vivo Development Immune Response Big Data 40

The Pharma Data

JANUARY 6, 2021

This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. These items are uncertain and depend on various factors that could have a material impact on GAAP net income for the guidance period. Forward-Looking Statements.

Production 52

Production Marketing Containment Sales 52

The Pharma Data

NOVEMBER 15, 2020

Prior to Celgene, she held leadership roles in marketing, sales and new business development from 2002 to 2011 at Johnson & Johnson. Shah previously served as Chief Executive Officer and a member of the board of directors of BioMotiv, an accelerator company aligned with the Harrington Project for Discovery & Development, a U.S.

Clinical Trials 40

Clinical Trials Clinical Trials Production Trials 40

Pharmaceutical Technology

MAY 11, 2008

Over the last three to five years technology has been developed that makes it possible to track and trace pharmaceutical units, even down to item level. In the US solid dosage forms are distributed as containers of tablets and these can only be coded on the container and not on a per-item basis.

Drugs 130

Drugs Packaging Packaging Production 130

The Pharma Data

OCTOBER 19, 2020

Bioprocess Solutions Division expands dynamically; positive development of the Lab Products & Services Division. Yet the further development of the currently worsening pandemic situation may considerably affect these results.” ” Business development of the Group. percent; sales revenue up 25.2

Sales 52

Sales Production Life Science Development 52

The Pharma Data

AUGUST 6, 2020

Research and development expenses increased 90% to $2.5 Research and development expense. Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. billion in the quarter primarily due to $1.1 0.9B – $1.1B.

Production 52

Production Branding Marketing Containment 52

The Pharma Data

NOVEMBER 5, 2020

This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Research and development. . These items are uncertain and depend on various factors that could have a material impact on GAAP net income for the guidance period. Forward-Looking Statements. 144,572. .

Production 52

Production Marketing Sales Manufacturing 52